PBTLI scientists have over 25 years of experience conducting contract studies, following industry standards of speed, confidentiality, and reliability.
Alvin V. Terry, Jr., Ph.D.
President and CEO
Dr. Terry is a tenured Regents Professor and the Chair of the Department of
Pharmacology and Toxicology at the Medical College of Georgia at Augusta
University (AU) in Augusta, Georgia, USA. He also holds joint appointments
as Professor of Neurology and Graduate Studies at AU and is a licensed pharmacist
in Georgia and South Carolina. He has more than 25 years of research experience
in neuropharmacology, drug discovery, and neurotoxicology, and he has conducted
numerous collaborative projects and contracts with the pharmaceutical industry.
Lowell Greenbaum, Ph.D.
Dr. Greenbaum, Professor Emeritus and former Vice President for Research at the Medical College of Georgia, has over 40 years of research experience in pharmacology and biochemistry and is internationally recognized for his accomplishments as a researcher as well as for his leadership roles in the field. Dr. Greenbaum has served on the board of directors of several organizations that served to facilitate interactions and joint ventures between academia and industry.
William F. Bruggemann, III
Mr. Bruggemann has served as Chief Financial Officer of PBLTI since its inception in 2000. He has over 30 years of experience as a certified public accountant for private companies as well as the armed services.